Suppr超能文献

结合型次级 12α-羟化胆酸促进肝纤维化。

Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis.

机构信息

Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China; Human Metabolomics Institute, Inc., Shenzhen, Guangdong 518109, China.

Department of Hepatobiliary Surgery, The Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, Jiangsu 210009, China.

出版信息

EBioMedicine. 2021 Apr;66:103290. doi: 10.1016/j.ebiom.2021.103290. Epub 2021 Mar 19.

Abstract

BACKGROUND

Significantly elevated serum and hepatic bile acid (BA) concentrations have been known to occur in patients with liver fibrosis. However, the roles of different BA species in liver fibrogenesis are not fully understood.

METHODS

We quantitatively measured blood BA concentrations in nonalcoholic steatohepatitis (NASH) patients with liver fibrosis and healthy controls. We characterized BA composition in three mouse models induced by carbon tetrachloride (CCl), streptozotocin-high fat diet (STZ-HFD), and long term HFD, respectively. The molecular mechanisms underlying the fibrosis-promoting effects of BAs were investigated in cell line models, a 3D co-culture system, and a Tgr5 (HSC-specific) KO mouse model.

FINDINGS

We found that a group of conjugated 12α-hydroxylated (12α-OH) BAs, such as taurodeoxycholate (TDCA) and glycodeoxycholate (GDCA), significantly increased in NASH patients and liver fibrosis mouse models. 12α-OH BAs significantly increased HSC proliferation and protein expression of fibrosis-related markers. Administration of TDCA and GDCA directly activated HSCs and promoted liver fibrogenesis in mouse models. Blockade of BA binding to TGR5 or inhibition of ERK1/2 and p38 MAPK signaling both significantly attenuated the BA-induced fibrogenesis. Liver fibrosis was attenuated in mice with Tgr5 depletion.

INTERPRETATION

Increased hepatic concentrations of conjugated 12α-OH BAs significantly contributed to liver fibrosis via TGR5 mediated p38MAPK and ERK1/2 signaling. Strategies to antagonize TGR5 or inhibit ERK1/2 and p38 MAPK signaling may effectively prevent or reverse liver fibrosis.

FUNDINGS

This study was supported by the National Institutes of Health/National Cancer Institute Grant 1U01CA188387-01A1, the National Key Research and Development Program of China (2017YFC0906800); the State Key Program of National Natural Science Foundation (81430062); the National Natural Science Foundation of China (81974073, 81774196), China Postdoctoral Science Foundation funded project, China (2016T90381), and E-institutes of Shanghai Municipal Education Commission, China (E03008).

摘要

背景

已知血清和肝胆汁酸(BA)浓度显著升高发生在肝纤维化患者中。然而,不同 BA 种类在肝纤维化发生中的作用尚不完全清楚。

方法

我们定量测量了非酒精性脂肪性肝炎(NASH)伴肝纤维化患者和健康对照者的血液 BA 浓度。我们分别用四氯化碳(CCl)、链脲佐菌素高脂饮食(STZ-HFD)和长期高脂饮食诱导的三种小鼠模型来描述 BA 组成。在细胞系模型、三维共培养系统和 Tgr5(HSC 特异性)KO 小鼠模型中研究了 BA 促进纤维化的分子机制。

发现

我们发现一组共轭 12α-羟化(12α-OH)BA,如牛磺脱氧胆酸(TDCA)和甘氨脱氧胆酸(GDCA),在 NASH 患者和肝纤维化小鼠模型中显著增加。12α-OH-BA 显著增加了 HSC 的增殖和纤维化相关标志物的蛋白表达。TDCA 和 GDCA 的给药直接激活了 HSC,并在小鼠模型中促进了肝纤维化。BA 与 TGR5 结合的阻断或 ERK1/2 和 p38 MAPK 信号通路的抑制均显著减弱了 BA 诱导的纤维化。Tgr5 耗竭的小鼠肝纤维化减轻。

结论

肝内浓度升高的共轭 12α-OH-BA 通过 TGR5 介导的 p38MAPK 和 ERK1/2 信号显著促进肝纤维化。拮抗 TGR5 或抑制 ERK1/2 和 p38 MAPK 信号的策略可能有效预防或逆转肝纤维化。

资助

本研究由美国国立卫生研究院/国立癌症研究所 U01CA188387-01A1 资助,国家重点研发计划(2017YFC0906800);国家重点基础研究发展计划(81301964);国家自然科学基金(81974073、81774196),中国博士后科学基金资助项目,中国(2016T90381),上海市教育委员会电子信息科学与工程E-研究所,中国(E03008)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b7a/8010625/5c3cfa0e07e2/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验